Mohammed Alahmari

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular BiologyEngineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Discovery of Cyclic Peptide Inhibitors Targeting PD-L1 for Cancer Immunotherapy”.

Discovery of Cyclic Peptide Inhibitors Targeting PD-L1 for Cancer Immunotherapy

Journal of Medicinal Chemistry(2022)10.1021/acs.jmedchem.2c00539

N/A

0DataRank · unranked

46 citations

Zhen Zhao, Hao Liu, Umar‐Farouk Mamani, Bahaa Mustafa, Pratik Adhikary +8 more

Discovery of Anti‐CD47 Peptides as Innate Immune Checkpoint Inhibitors

Advanced Therapeutics(2023)10.1002/adtp.202300114

N/A

0DataRank · unranked

1 citations

John Fetse, Sashi Kandel, Chien‐Yu Lin, Pratik Adhikary, Umar‐Farouk Mamani +5 more

Delivery of a STING Agonist Using Lipid Nanoparticles Inhibits Pancreatic Cancer Growth

International Journal of Nanomedicine(2024)10.2147/ijn.s462213

N/A

0DataRank · unranked

17 citations

Pratikkumar Patel, Umar‐Farouk Mamani, Yuhan Guo, Sushil Koirala, Chien‐Yu Lin +4 more

Exploring Multivalency in the Development of Anti-PD-L1 Peptides for Cancer Immunotherapy

Pharmaceutical Research(2024)10.1007/s11095-024-03803-1

N/A

0DataRank · unranked

2 citations

Mohammed Nurudeen Ibrahim, Yanli Liu, John Fetse, Chien‐Yu Lin, Sashi Kandel +6 more